Loss of SRY‐box2 (SOX2) expression and its impact on survival of patients with oesophageal adenocarcinoma

BACKGROUND: Oesophageal adenocarcinoma (OAC) is a highly aggressive malignancy with poor survival, which is highly variable amongst patients with comparable conventional prognosticators. Therefore molecular biomarkers are urgently needed to improve the prediction of survival in these patients. SRY (...

Descripción completa

Detalles Bibliográficos
Autores principales: ten Kate, F. J. C., van Olphen, S. H., Bruno, M. J., Wijnhoven, B. P. L., van Lanschot, J. J. B., Looijenga, L. H. J., Fitzgerald, R. C., Biermann, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600089/
https://www.ncbi.nlm.nih.gov/pubmed/28692180
http://dx.doi.org/10.1002/bjs.10553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600089/
https://www.ncbi.nlm.nih.gov/pubmed/28692180
http://dx.doi.org/10.1002/bjs.10553

Ejemplares similares